Fluoxetine-induced memory impairment in four family members

International Journal of Psychiatry in Medicine

Volumn 34, Issue 2, 2004, Pages 197-200

  Huang, Shu Chi ^a   Tsai, Shih Jen ^b   Chang, Joseph C C ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Fluoxetine; Memory impairment; Side effect

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; BRAIN FUNCTION; CASE REPORT; DEPRESSION; DRUG INDUCED DISEASE; FAMILY HISTORY; FAMILY LIFE; FEMALE; HUMAN; LEARNING; MEMORY; MEMORY DISORDER; RECEPTOR BLOCKING; SIDE EFFECT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMORY DISORDERS; PHENOTYPE; SEROTONIN UPTAKE INHIBITORS;

EID: 4344580775     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/DY6D-33BP-5WPB-1VDX     Document Type: Article

References (11)

1. Meneses A, Hong E. Effect of fluoxetine on learning and memory involves multiple 5-HT systems. Pharmacol Biochem Behav 1995;52:341-346.
2. Mirow S. Cognitive dysfunction associated with fluoxetine. American Journal of Psychiatry 1991;148:948-949.
3. Bradley SJ, Kulik L. Fluoxetine and memory impairment. Journal of the American Academy of Child and Adolescent Psychiatry 1993;32:1078-1079.
4. Bangs ME, Petti TA, Janus MD. Fluoxetine-induced memory impairment in an adolescent. Journal of the American Academy of Child and Adolescent Psychiatry 1994;33:1303-1306.
5. Curran HV, Sakulsriprong M, Lader M. Antidepressants and human memory: An investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology 1988;95:520-527.
6. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: Focus on newer generation compounds. Psychopharmacology 1994;114:559-565.
7. Buhot MC, Martin S, Segu L. Role of serotonin in memory impairment. Annals of Medicine 2000;32:210-221.
8. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 2001;50:260-265.
9. Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000;101:305-312.
10. Linnarsson S, Bjorklund A, Ernfors P. Learning deficit in BDNF mutant mice. European Journal of Neuroscience 1997;9:2581-2587.
11. Croll SD, Suri C, Compton DL, et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 1999;93:1491-1506.